Altimmune ALT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's accounts payable?
- Altimmune (ALT) reported accounts payable of $1.53M in Q1 2026.
- How has Altimmune's accounts payable changed year-over-year?
- Altimmune's accounts payable increased by 42.1% year-over-year, from $1.08M to $1.53M.
- What is the long-term trend for Altimmune's accounts payable?
- Over 5 years (2020 to 2025), Altimmune's accounts payable has grown at a 34.7% compound annual growth rate (CAGR), from $612.29K to $2.72M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.